PHATHOM PHARMACEUTICALS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 1,701,627 | $10,669,201 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2025 |
| June 30, 2025 | 1,461,895 | $14,019,573 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2025 |
| Sept. 30, 2025 | 1,537,218 | $18,093,056 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 14, 2025 |
| Dec. 31, 2025 | 1,331,669 | $22,092,389 | 0.13% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 1,340,916 | $14,897,577 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 21, 2026 |
| June 30, 2026 | 1,307,247 | $14,183,630 | 0.09% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 10, 2026 |
| Sept. 30, 2026 | 2,942,432 | $21,479,754 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 13, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.